综合性安全评估Withania somnifera (阿什瓦甘达):基于人工智能驱动的元分析和基于定量结构-活性关系的毒性评估
Yotam Ronen1, Coralie Ebert1, Bat-Chen Tamim-Yecheskel1
1MeNow Ltd., Ramat-Gan, Israel.
Frontiers in nutrition
|December 10, 2025
概括
阿什瓦甘达根比非根部件和大多数其他草药补充剂更安全,特别是在肝脏和生殖健康方面. 这项研究支持传统的使用,并突出了AI.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 草药的安全性 草药的安全性
- 计算化学的计算化学
背景情况:
- 维坦尼亚·索姆尼费拉 (Ashwagandha) 是一种适应性草药,具有传统的阿育吠陀用途.
- 关于阿什瓦甘达的安全信息存在矛盾,特别是关于其生物活性化合物,维他诺化物.
- 评估草药补充剂的安全性需要区分不同的植物部位.
研究的目的:
- 评估阿什瓦甘达根与非根部分的安全性.
- 将阿什瓦甘达与其他草药补充剂的安全性进行比较,重点关注肝脏和生殖毒性.
- 为全面的安全评估利用人工智能方法.
主要方法:
- 使用自然语言处理 (NLP) 进行系统的文献审查.
- 用于毒性预测的定量结构-活性关系 (QSAR) 建模.
- 对植物部位的元数据分析和与其他草药补充剂的比较.
主要成果:
- 与非根部件相比,阿什瓦甘达根在肝脏和生殖毒性方面表现出更高的安全性.
- 阿什瓦甘达根表现出比大多数其他评估的草药补充剂更好的安全性.
- 非根部份显示有更高的毒性潜力,但仍然与其他食用植物和草药补充剂相当.
结论:
- 维坦尼亚·索姆尼费拉 (阿什瓦甘达) 的根具有有利的安全性,支持传统使用.
- 区分植物部分对于准确的草药补充剂安全性评估至关重要.
- 人工智能方法可以增强草药产品安全性的传统毒理学评估.
相关概念视频
Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Mutagenicity and Carcinogenicity
1.8K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


